Literature DB >> 24703893

Postprandial hypotension in de novo Parkinson's disease: a comparison with orthostatic hypotension.

Tadashi Umehara1, Chizuko Toyoda2, Hisayoshi Oka3.   

Abstract

BACKGROUND: Postprandial hypotension (PPH) is often associated with Parkinson's disease (PD). However, its mechanism remains to be fully defined. We investigated the mechanism of PPH and compared it with that of orthostatic hypotension (OH).
METHODS: The subjects were 37 patients with de novo PD and 10 healthy age-matched controls. We studied changes in blood pressure (BP), plasma norepinephrine concentrations (NE), plasma insulin, plasma glucose concentrations during a 75-g oral glucose tolerance test (75-g OGTT). Changes in BP and NE were also examined with head-up tilt-table testing (HUT).
RESULTS: The maximum fall in systolic BP (SBP) on 75-g OGTT (⊿SBPPPH) significantly correlated with that on HUT (r = 0.359, p < 0.05). On 75-g OGTT, ⊿SBPPPH significantly correlated with SBP after 20 min of rest in the supine position (r = 0.394, p < 0.01) and the time in which SBP reached its lowest (r = 0.436, p < 0.01). ⊿SBPPPH did not correlate with NE, plasma insulin and glucose concentrations after glucose loading, but significantly negatively correlated with NE measured after 20 min resting in the supine position (r = -0.347, p < 0.05). Clinical characteristics, including the presence of constipation, did not differ significantly between patients with and those without PPH.
CONCLUSIONS: In PD, systemic sympathetic denervation, impaired baroreflex-cardiovagal gain, and insufficiency of compensatory sympathetic nervous activation including lack of baroreflex-sympathoneural gain for postprandial splanchnic vessel pooling seem to be associated with PPH. Systemic sympathetic denervation and baroreflex failure seem to contribute to both pronounced morbidity and the development of PPH and OH.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autonomic failure; Orthostatic hypotension; Parkinson's disease; postprandial hypotension

Mesh:

Substances:

Year:  2014        PMID: 24703893     DOI: 10.1016/j.parkreldis.2014.02.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

1.  Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson's Disease.

Authors:  Mark Dominic Latt; Simon Lewis; Olfat Zekry; Victor S C Fung
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

2.  Predictors of postprandial hypotension in elderly patients with de novo Parkinson's disease.

Authors:  Tadashi Umehara; Atsuo Nakahara; Hiromasa Matsuno; Chizuko Toyoda; Hisayoshi Oka
Journal:  J Neural Transm (Vienna)       Date:  2016-07-08       Impact factor: 3.575

Review 3.  Postprandial hypotension in neurological disorders: systematic review and meta-analysis.

Authors:  Antun Pavelić; Magdalena Krbot Skorić; Luka Crnošija; Mario Habek
Journal:  Clin Auton Res       Date:  2017-06-24       Impact factor: 4.435

4.  Clinical characteristics of supine hypertension in de novo Parkinson disease.

Authors:  Tadashi Umehara; Hiromasa Matsuno; Chizuko Toyoda; Hisayoshi Oka
Journal:  Clin Auton Res       Date:  2015-11-27       Impact factor: 4.435

5.  Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies.

Authors:  Hisayoshi Oka; Tadashi Umehara; Atsuo Nakahara; Hiromasa Matsuno
Journal:  BMC Neurol       Date:  2020-09-18       Impact factor: 2.474

6.  Reduced central sympathetic activity in Parkinson's disease.

Authors:  Heidrun H Krämer; Gothje Lautenschläger; Michael de Azevedo; Kathrin Doppler; Anne Schänzer; Christoph Best; Wolfgang H Oertel; Iris Reuter; Claudia Sommer; Frank Birklein
Journal:  Brain Behav       Date:  2019-11-05       Impact factor: 2.708

Review 7.  The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review.

Authors:  Panagiotis Zis; Roberto Erro; Courtney C Walton; Anna Sauerbier; Kallol Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2015-07-09

Review 8.  Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence.

Authors:  Lorena Cuenca-Bermejo; Pilar Almela; Javier Navarro-Zaragoza; Emiliano Fernández Villalba; Ana-María González-Cuello; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.